These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23811589)

  • 21. The potential use of antisclerostin therapy in chronic kidney disease-mineral and bone disorder.
    Costa AG; Bilezikian JP; Lewiecki EM
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):324-9. PubMed ID: 26050118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method for vibrational assessment of cortical bone.
    Song Y; Gunaratne GH
    Chaos; 2006 Sep; 16(3):033102. PubMed ID: 17014207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New Developments in CKD-MBD. Bone quality and fracture in patients with chronic kidney disease].
    Iwasaki Y; Yamato H
    Clin Calcium; 2014 Dec; 24(12):1809-14. PubMed ID: 25423926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenine-induced chronic kidney disease induces a similar skeletal phenotype in male and female C57BL/6 mice with more severe deficits in cortical bone properties of male mice.
    Metzger CE; Swallow EA; Stacy AJ; Allen MR
    PLoS One; 2021; 16(4):e0250438. PubMed ID: 33891630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Influence of Chronic Kidney Disease on the Structural and Mechanical Properties of Canine Bone.
    Shipov A; Shahar R; Sugar N; Segev G
    J Vet Intern Med; 2018 Jan; 32(1):280-287. PubMed ID: 29193308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effects of glucocorticoid on bone architecture and strength].
    Soen S
    Clin Calcium; 2013 Jul; 23(7):993-9. PubMed ID: 23811587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Independent and combined contributions of cancellous and cortical bone deficits to vertebral fracture risk in postmenopausal women.
    Qiu S; Rao DS; Palnitkar S; Parfitt AM
    J Bone Miner Res; 2006 Nov; 21(11):1791-6. PubMed ID: 17002584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diabetes mellitus and osteoporosis. How to start drug therapy for osteoporosis in patients with diabetes mellitus].
    Yamaguchi T
    Clin Calcium; 2012 Sep; 22(9):1403-9. PubMed ID: 22932296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive approach to fragility fractures.
    Rebolledo BJ; Unnanuntana A; Lane JM
    J Orthop Trauma; 2011 Sep; 25(9):566-73. PubMed ID: 21654529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is cortical bone hip? What determines cortical bone properties?
    Epstein S
    Bone; 2007 Jul; 41(1 Suppl 1):S3-8. PubMed ID: 17466615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Important determinants of bone strength: beyond bone mineral density.
    Friedman AW
    J Clin Rheumatol; 2006 Apr; 12(2):70-7. PubMed ID: 16601540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
    Felsenberg D; Boonen S
    Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of aging and therapy on the structural properties and strength of vertebral body].
    Kishimoto H
    Clin Calcium; 2013 Jul; 23(7):959-66. PubMed ID: 23811583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone strength and its determinants.
    Ammann P; Rizzoli R
    Osteoporos Int; 2003; 14 Suppl 3():S13-8. PubMed ID: 12730800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease.
    Steller Wagner Martins C; Jorgetti V; Moysés RMA
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):243-250. PubMed ID: 29608453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased calcium content and inhomogeneity of mineralization render bone toughness in osteoporosis: mineralization, morphology and biomechanics of human single trabeculae.
    Busse B; Hahn M; Soltau M; Zustin J; Püschel K; Duda GN; Amling M
    Bone; 2009 Dec; 45(6):1034-43. PubMed ID: 19679206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
    Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteosynthesis systems in fragility fracture.
    Sessa G; Evola FR; Costarella L
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):69-70. PubMed ID: 21970929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the structure and strength of bones in celiac disease patients.
    Ferretti J; Mazure R; Tanoue P; Marino A; Cointry G; Vazquez H; Niveloni S; Pedreira S; Mauriño E; Zanchetta J; Bai JC
    Am J Gastroenterol; 2003 Feb; 98(2):382-90. PubMed ID: 12591059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.